Associate Director/Director Quantitative Pharmacology

1 messages 1 people Latest: Feb 24, 2021
Our Client on the East Coast is looking for recognized leader in Pharmacometrics. This role can be located in Cambridge, Philadelphia or Montreal. KEY RESPONSIBILITIES * Partner with Head of Nonclinical Development, Program Team leaders and R&D staff to lead the pharmacometrics and quantitative PK/PD strategy for discovery and development programs * As a member of project teams, the individual will be responsible for applying model-based approaches to support compartmental and mechanism-based PK/PD analysis, evaluation of FIH dose and regimen recommendations. * Develop and execute strategies for mid-stage and late-stage Oncology programs to support regulatory questions and filings * Provide due-diligence and strategic regulatory advice/evaluations for oncology drug development programs * The successful incumbent will utilize a range of computational approaches (PK/PD, PBPK, pharmacometrics, systems-based, informatics). The scope of project responsibility will range from late discovery through registration. QUALIFICATIONS * A Ph.D. in a related field with years of relevant experience in modeling and simulation. * Excellent understanding of PK (NCA, compartmental) and PK/PD principles. * Expertise in the application of Phoenix WinNonlin, PBPK related software, and R is required. * Experience with PopPK model development with regulatory reporting is a plus. * Superior communication skills (both written and oral) and attention to detail For more information please contact: TJ Elder Search Consultant Pre-Clinical Development O: 413.458.6124 C: 413.207.7676 https://www.linkedin.com/in/tjelder/ [email protected]<mailto:[email protected]> [cid:[email http://www.stem-sourcing.com/ Please Note: The information in this e-mail message is legally privileged and confidential information intended only for the use of the addressee(s) named above. If you, the reader of this message, are not the intended recipient, you are hereby notified that you should not further disseminate, distribute, or forward this e-mail message. If you have received this e-mail in error, please notify the sender as soon as possible. In addition, please delete the erroneously received message from any device/media where the message is stored.